Navigation Links
A New Drug for Halting Metastatic Kidney Cancer

A recent research reports the efficacy of a pharmaceutical drug named Sunitinib in halting the progress of metastatic kidney cancer. A comparative study of interferon and// sunitinib treatments found that sunitinib is more efficient in halting the progress of metastatic kidney cancer.

The work was published recently in the prestigious international medical journal, The New England Journal of Medicine and involved medical co-researchers from the Oncology Department of the University Hospital of Navarra, in collaboration with the Clinical Trials Area of the same Department.

To date the usual treatment for kidney cancer of a metastatic nature has been based solely on immunotherapy. In phase III of the research sunitinib was compared with interferon (a type of immunotherapy) in 750 patients with metastatic kidney cancer and it was shown that sunitinib is more efficient in halting the progress of the disease. 101 medical centres from all over the world took part in the research.

Given the short period of follow-up in the research, the effect of the treatment on survival rates could not be corroborated. Although, in general, the treatment is well tolerated, certain side effects can occur and have to be taken into consideration - hypothyroidism, high blood pressure and fatigue.

Metastatic kidney cancer is one of the cancer pathologies the treatment of which has made least progress in recent years. The usual treatment with immunotherapy had not shown clearly positive results in many patients. Sunitinib is one of the few pharmaceutical drugs that provide clear improvements in this type of cancer.

The mechanism of functioning of sunitinib is in blocking the generation of new blood vessels. Tumors, in order to grow, need to develop blood vessels and this pharmaceutical drug impedes their growth, blocking a factor known as VEGF, and other similar ones, which stimulate vascular growth. The use of sunitinib in Spain is t o be approved shortly for the treatment of kidney cancer with metastasis although, at the University Hospital, it has been employed with over 40 patients for the last two years, using clinical trials.

Source-Eurekalert
PRI
'"/>




Related medicine news :

1. Anti-Retrovirals Capable of Halting Mental Illness in HIV Patients
2. Cholesterol-lowering Drug Effective at Halting Early Atherosclerosis
3. IMP3 the Novel Biomarker for Metastatic Cancer
4. Researchers Find Stem-cell Therapy Effective in Targeting Metastatic Cancer
5. Is Diabetes the Leading Cause of Kidney Failure in India
6. Kidney Stones - Interesting New Research implicates bacteria as its cause
7. Moderate Use of Analgesics - Not Associated With Kidney Dysfunction
8. New Dietary Approach To Manage Kidney Stones
9. Kidney cancer on the rise
10. Kidney function can be affected by lead exposure
11. Kidney Failure after Non-Kidney Transplants
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/27/2017)... ... June 27, 2017 , ... ... Orthodontics is a dental specialty that focuses on treating alignment and occlusion irregularities. ... aesthetics and function. , North Hollywood dentist , Dr. Garemani, along ...
(Date:6/27/2017)... ... ... Children’s National Health System received top honors in the 2017-18 U.S News & ... of more than 1500 neonatal intensive care units coast to coast. Children’s ... the top performing children’s hospitals in the country. , In addition to achieving ...
(Date:6/26/2017)... ... 2017 , ... Antoine Dental Center is now offering various types of dental implants ... as a support for prosthetic teeth, such as crowns, bridges, or dentures. An implant is ... sturdy, lasting new root for the tooth. , Several types of dental implants are ...
(Date:6/26/2017)... ... June 26, 2017 , ... The Centers for Advanced Orthopaedics ... of Richard Robinson as chief operating officer (COO). In this role, Robinson brings ... track record of simplifying business processes and developing growth strategies to increase market ...
(Date:6/26/2017)... New Mexico (PRWEB) , ... June 26, 2017 ... ... dysfunction, anorgasmia, and urinary leakage is revolutionizing the way women look and feel ... is tackling the problem of female sexual dysfunction and urinary leakage head on ...
Breaking Medicine News(10 mins):
(Date:5/30/2017)... , May 30, 2017 Hill-Rom Holdings, Inc. ... Annual Global Healthcare Conference on Tuesday, June 13, 2017, ... John Greisch , Hill-Rom,s president and chief executive officer, is ... The live audio webcast can be accessed at http://ir.hill-rom.com/events.cfm ... conclusion of the live event through September 13, 2017. ...
(Date:5/29/2017)... May 29, 2017  Cellect Biotechnology Ltd. (NASDAQ: ... which enables the functional selection of stem cells, today ... the first quarter ended March 31 st , 2017. ... accomplishments in the first quarter of 2017," said Dr. ... we announced the treatment of the first blood cancer ...
(Date:5/26/2017)... SANTA BARBARA, Calif. , May 25, 2017 /PRNewswire-USNewswire/ ... the United States , Direct Relief is working ... of overdose-reversing Naloxone available at no cost to community ... and other nonprofit providers nationwide. "Pfizer ... expanding access to medicines and ensuring patient safety through ...
Breaking Medicine Technology: